Notably, AKT1, EGFR, IL6, STAT3, BCL2, CASP3, and JUN were identified as the top seven targets (degree >80) and may be key targets of QJSB in treating leukopenia. This evidence concerns the gene AKT1 and Decreased total leukocyte count.